The First Affiliated Hospital of Nanjing Medical University
The First Affiliated Hospital of Nanjing Medical University
Nanjing, China21 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Treatment Strategy for Patients With RA-ILD | Rheumatoid Arthritis Associated Interstitial Lung Disease | Not yet recruiting | Phase 4 | 2026-09-03 | NCT07643038 | |
| Severe Complications During Ventricular Tachycardia or Premature Ventricular Complex Ablation | Arrhythmias, Cardiac, Cardiac Complexes, Premature, Cardiac Conduction System Disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Tachycardia, Ventricular Premature Complexes, cardiovascular disorder, heart disorder, ventricular tachycardia | Recruiting | Not stated | 2026-08-20 | NCT07777744 | |
| Guo's Aortic Arch Reconstruction: A Multicenter, Prospective Study of the Novel WeFlow-Tribranch System (GENIUS Study) | Aneurysm, Aneurysm, Aortic Arch, aortic aneurysm, aortic disorder, cardiovascular disorder, thoracic aortic aneurysm, vascular disorder | Recruiting | Not applicable | 2026-05-01 | NCT06385379 | |
| A Study Comparing Haploidentical Hematopoietic Stem Cell Transplantations (HSCTs) From Young Non-first-degree and Older First-degree Donors in Hematological Malignancies | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, hematologic disorder, leukemia, myelodysplastic syndrome, neoplasm | Active, not recruiting | Phase 3 | 2026-04-09 | NCT04547049 | |
| Study on the Treatment of HER2-negative Breast Cancer Brain Metastases With Radiotherapy Combined With Anlotinib | HER2-Negative Breast Cancer | Recruiting | Phase 2 | 2026-02-09 | NCT07396454 | |
| AI-assisted Subtyping-directed Precision Treatment in Acute Aortic Dissection | Acute Aortic Syndrome, Aneurysm, Aortic Dissection, Dissection, Blood Vessel, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, aortic disorder, cardiovascular disorder, vascular disorder | Not yet recruiting | Not applicable | 2026-02-02 | NCT07382375 | |
| UB-VV410 in Subjects With Active Refractory Systemic Lupus Erythematosus or Lupus Nephritis | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Skin and Connective Tissue Diseases, Urogenital Diseases, autoimmune disease, connective tissue disorder, glomerulonephritis, immune system disorder, kidney disorder, lupus nephritis, nephritis, systemic lupus erythematosus, urinary system disorder | Recruiting | Phase 1 | 2026-01-23 | NCT07109986 | |
| Vitamin B Supplementation for Patients Undergoing Cardiovascular Surgery | Cardiovascular Surgical Procedures; Major Adverse Cardiovascular Events (MACE) | Not yet recruiting | Not applicable | 2026-01-16 | NCT07348328 | |
| Efficacy, Safety, and Pharmacokinetics of LP-005 Injection in PNH Patients. | Hemic and Lymphatic Diseases, Hemoglobinuria, Paroxysmal, anemia, bone marrow disorder, hematologic disorder, hemolytic anemia, myelodysplastic syndrome | Active, not recruiting | Phase 2 | 2026-01-16 | NCT07212426 | |
| Efficacy, Safety, and Pharmacokinetics of LP-005 Injection in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) | Hemic and Lymphatic Diseases, Hemoglobinuria, Paroxysmal, anemia, bone marrow disorder, hematologic disorder, hemolytic anemia, myelodysplastic syndrome, paroxysmal nocturnal hemoglobinuria | Not yet recruiting | Phase 2 | 2025-12-05 | NCT07266155 | |
| The Impact of Transjugular Intrahepatic Portosystemic Shunt on Recompensation in Patients With Decompensated Liver Cirrhosis | Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cirrhosis of liver | Recruiting | Not stated | 2025-12-05 | NCT07172035 | |
| UB-VV400 in Combination With Rapamycin in Relapsed or Refractory B-cell Malignancies | Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, large B-cell lymphoma | Recruiting | Phase 1 | 2025-09-18 | NCT06743503 | |
| The Efficacy and Safety of Third-generation TKIs Combined With Azacitidine and Bcl-2 Inhibitor in Patients With CML-MBP | Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Myeloproliferative Disorders, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bone marrow disorder, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Not stated | 2025-06-03 | NCT06390306 | |
| Nimotuzumab Plus Definite Chemoradiotherapy(dCRT) in Elderly Patients With Esophageal Squamous Cell Carcinoma | Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, digestive system disorder, digestive system neoplasm, epithelial neoplasm, esophageal disorder, esophageal squamous cell carcinoma, neoplasm, squamous cell carcinoma, squamous cell neoplasm | Recruiting | Phase 2 | 2025-05-25 | NCT06988956 | |
| Omission of ALND in Breast Cancer Patients With Axillary pCR | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Not applicable | 2024-12-30 | NCT05939830 | |
| Catheter Ablation of Haemodynamically Not-tolerated Electrical Storm in Structural Heart Disease | Arrhythmias, Cardiac, Cardiac Conduction System Disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Tachycardia, cardiovascular disorder, heart disorder, ventricular tachycardia | Not yet recruiting | Not applicable | 2024-06-12 | NCT06455020 | |
| Concomitant Tricuspid Repair in Patients With Left Heart Surgery | cardiovascular disorder, heart disorder, heart valve disorder, mitral valve insufficiency, tricuspid valve insufficiency | Not yet recruiting | Not applicable | 2023-12-14 | NCT05595187 | |
| Catheter Ablation in Atrial Fibrillation Patients With HFpEF (STABLE-SR IV Trial) | Arrhythmias, Cardiac, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorder | Recruiting | Not applicable | 2023-12-11 | NCT06125925 | |
| Effects of Different Treatment Schemes on the Regulation and Recurrence of Graves' Disease | Chemically-Induced Disorders, Disease Attributes, Graves disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Relapse, autoimmune disease, disease of orbital part of eye adnexa, endocrine system disorder, exophthalmos, eye disorder, goiter, hyperthyroidism, immune system disorder, psychiatric disorder, substance withdrawal syndrome, substance-related disorder, thyroid gland disorder | Recruiting | Phase 4 | 2023-12-11 | NCT05461820 | |
| Carrelizumab Combined With Concurrent Radiotherapy and Chemotherapy for Unresectable Esophageal Squamous Cell Carcinoma | Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, digestive system disorder, digestive system neoplasm, epithelial neoplasm, esophageal disorder, esophageal squamous cell carcinoma, neoplasm, squamous cell carcinoma, squamous cell neoplasm | Enrolling by invitation | Not applicable | 2023-09-21 | NCT06048926 | |
| A Clinical Study of the Value of Circulating Free Methylated EBV DNA in Extranodal NK/T Cell Lymphoma | Extranodal Natural Killer/T-cell Lymphoma | Not yet recruiting | Not applicable | 2022-04-25 | NCT05343377 |